Daplyza-M (Dapagliflozin + Metformin HCl) is indicated in adults for the treatment of type 2 diabetes mellitus as an adjunct to diet and exercise:
• In patients insufficiently controlled on their maximally tolerated dose of Metformin HCl alone.
• In combination with other medicinal products for the treatment of diabetes in patients insufficiently controlled with Metformin HCl and these medicinal products.
• In patients already being treated with the combination of Dapagliflozin and Metformin HCl as separate tablets.